Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SIRIUS Cost Data Suggests Higher Inpatient Payment Level For Eluting Stents

This article was originally published in The Gray Sheet

Executive Summary

Cost-effectiveness data collected by Johnson & Johnson/Cordis from trials of its Cypher sirolimus-eluting coronary stent will justify assigning the device to a new diagnosis-related group (DRG) in time for the expected 2003 U.S. launch, according to Cordis

You may also be interested in...



Cypher In-Stent Restenosis Treatment Safety Upheld By J&J Investigators

Eight-month follow-up of Johnson & Johnson/Cordis' 41-patient study evaluating the Cypher sirolimus-eluting stent for treating in-stent restenosis suggests the procedure is safe and effective, investigators reported March 19 at the American College of Cardiology annual scientific sessions in Atlanta

Cypher In-Stent Restenosis Treatment Safety Upheld By J&J Investigators

Eight-month follow-up of Johnson & Johnson/Cordis' 41-patient study evaluating the Cypher sirolimus-eluting stent for treating in-stent restenosis suggests the procedure is safe and effective, investigators reported March 19 at the American College of Cardiology annual scientific sessions in Atlanta

Drug-Coated Stents Will Pay Their Way If Priced At $2,500 Or Below – Cohen

The ability of drug-eluting stents to reduce the need for revascularization procedures justifies a price premium of up to $1,500 over regular stents, according to a cost-efficiency model by cardiologist David Cohen, MD, Beth Israel Deaconess Medical Center

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT016310

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel